Back to UBS Group AG UBS Group AG

NSRXNSRX
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in NASUS PHARMA LTD

UBS Group AG previously held 0 shares of NSRX (NASUS PHARMA LTD), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$8,253

Total Shares Change

-1,241

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$3.50
0
2026-Q1
Increased
3,094
+718.5%
$6,8690.0%$4.75
18
2025-Q4
Decreased
378
-69.5%
$3,4590.0%$7.79
0
2025-Q3
New
1,241
-
$8,2530.0%$7.55
25

Other major holders of NSRX: BALYASNY ASSET MANAGEMENT L.P., Hudson Bay Capital Management LP, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used